Cargando…
Development of Natural-Based Bone Cement for a Controlled Doxorubicin-Drug Release
Osteosarcoma (OS) accounts for 60% of all global bone cancer diagnoses. Intravenous administration of Doxorubicin Hydrochloride (DOXO) is the current form of OS treatment, however, systemic delivery has been linked to the onset of DOXO induced cardiomyopathy. Biomaterials including calcium phosphate...
Autores principales: | Dewhurst, Rebecca Marie, Scalzone, Annachiara, Buckley, Joseph, Mattu, Clara, Rankin, Kenneth S., Gentile, Piergiorgio, Ferreira, Ana Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363953/ https://www.ncbi.nlm.nih.gov/pubmed/32733869 http://dx.doi.org/10.3389/fbioe.2020.00754 |
Ejemplares similares
-
pH-Triggered Adhesiveness and Cohesiveness of Chondroitin Sulfate-Catechol Biopolymer for Biomedical Applications
por: Scalzone, Annachiara, et al.
Publicado: (2020) -
A cytokine-induced spheroid-based in vitro model for studying osteoarthritis pathogenesis
por: Scalzone, Annachiara, et al.
Publicado: (2023) -
Editorial: Biofunctional materials and coatings for orthopaedic and dental applications
por: Ferreira, Ana Marina, et al.
Publicado: (2023) -
The Development of a Magnesium-Releasing and Long-Term Mechanically Stable Calcium Phosphate Bone Cement Possessing Osteogenic and Immunomodulation Effects for Promoting Bone Fracture Regeneration
por: Wu, Jun, et al.
Publicado: (2022) -
Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma
por: Brachi, Giulia, et al.
Publicado: (2019)